EAM
DRNA
Eventide Asset Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-377,000
| Closed | -$2.17M | – | 147 |
|
|
2017
Q3 | $2.17M | Hold |
377,000
| – | – | 0.12% | 102 |
|
|
2017
Q2 | $1.2M | Hold |
377,000
| – | – | 0.07% | 112 |
|
|
2017
Q1 | $1.28M | Hold |
377,000
| – | – | 0.08% | 102 |
|
|
2016
Q4 | $1.09M | Hold |
377,000
| – | – | 0.07% | 107 |
|
|
2016
Q3 | $2.22M | Hold |
377,000
| – | – | 0.14% | 94 |
|
|
2016
Q2 | $1.13M | Hold |
377,000
| – | – | 0.07% | 103 |
|
|
2016
Q1 | $2.02M | Hold |
377,000
| – | – | 0.11% | 102 |
|
|
2015
Q4 | $4.48M | Buy |
377,000
+61,700
| +20% | +$732K | 0.22% | 91 |
|
|
2015
Q3 | $2.59M | Buy |
315,300
+40,000
| +15% | +$328K | 0.15% | 93 |
|
|
2015
Q2 | $3.84M | Buy |
275,300
+133,200
| +94% | +$1.86M | 0.21% | 83 |
|
|
2015
Q1 | $3.42M | Buy |
142,100
+58,400
| +70% | +$1.4M | 0.26% | 79 |
|
|
2014
Q4 | $1.38M | Buy |
83,700
+20,000
| +31% | +$330K | 0.15% | 90 |
|
|
2014
Q3 | $811K | Hold |
63,700
| – | – | 0.11% | 94 |
|
|
2014
Q2 | $1.44M | Buy |
+63,700
| New | +$1.44M | 0.2% | 84 |
|